Diagnosis and Predicted Outcomes of Patients with Cystic Fibrosis Related Liver Disease Considered for Lung Transplantation
Anxiety associated with poor post operative outcomes has led to patients with Cystic Fibrosis Related Liver Disease (CFRLD) being denied a chance of lung transplant for fear of developing post-operative progressive hepatic impairment. We studied a total of 238 transplanted patients. Patients were di...
Saved in:
Published in | The Journal of heart and lung transplantation Vol. 40; no. 4; p. S318 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.04.2021
|
Online Access | Get full text |
Cover
Loading…
Abstract | Anxiety associated with poor post operative outcomes has led to patients with Cystic Fibrosis Related Liver Disease (CFRLD) being denied a chance of lung transplant for fear of developing post-operative progressive hepatic impairment.
We studied a total of 238 transplanted patients. Patients were divided into two groups CFRLD and Non-CFRLD based on our new criterion. Groups were compared first to assess validity of the diagnosis and then survival outcomes. A predictor of hepatic injury was devised by modifying the APRI (Aspartate aminotransferase-to-Platelet Ratio Index) scores to diagnose CFRLD and predict severity of liver disease.
The new diagnostic criteria for differentiating CFRLD from Non CFRLD was effective. This was supported by significant difference in serum Bilirubin from 6.1 to 9.4 micromole / L at 90 days post transplant (p = 0.0001). There was no significant difference in the survival between the two groups at short, medium or long term demonstrated by the Kaplan-Meier plot with survival of 85%, 73%, 47%, 18.6% and 4.7% at one, two, five, ten and 15 year respectively. A modified APRI score of greater than 0.2 had a sensitivity of 43.0% but a specificity of 82.5 % for predicting CFRLD and 46.5% sensitivity but 100% specificity in diagnosing an ultrasound/biopsy proven hepatic abnormality associated with CFRLD.
Patients with CFRLD and portal hypertension but with preserved hepatocellular function have a similar outcome to patients without CFRLD. Modified APRI sore is a highly specific non-invasive tool for diagnosis of CFRLD. |
---|---|
AbstractList | Anxiety associated with poor post operative outcomes has led to patients with Cystic Fibrosis Related Liver Disease (CFRLD) being denied a chance of lung transplant for fear of developing post-operative progressive hepatic impairment.
We studied a total of 238 transplanted patients. Patients were divided into two groups CFRLD and Non-CFRLD based on our new criterion. Groups were compared first to assess validity of the diagnosis and then survival outcomes. A predictor of hepatic injury was devised by modifying the APRI (Aspartate aminotransferase-to-Platelet Ratio Index) scores to diagnose CFRLD and predict severity of liver disease.
The new diagnostic criteria for differentiating CFRLD from Non CFRLD was effective. This was supported by significant difference in serum Bilirubin from 6.1 to 9.4 micromole / L at 90 days post transplant (p = 0.0001). There was no significant difference in the survival between the two groups at short, medium or long term demonstrated by the Kaplan-Meier plot with survival of 85%, 73%, 47%, 18.6% and 4.7% at one, two, five, ten and 15 year respectively. A modified APRI score of greater than 0.2 had a sensitivity of 43.0% but a specificity of 82.5 % for predicting CFRLD and 46.5% sensitivity but 100% specificity in diagnosing an ultrasound/biopsy proven hepatic abnormality associated with CFRLD.
Patients with CFRLD and portal hypertension but with preserved hepatocellular function have a similar outcome to patients without CFRLD. Modified APRI sore is a highly specific non-invasive tool for diagnosis of CFRLD. |
Author | Meachery, G. Dark, J. Khoshbin, E. Clark, S. Hudson, M. |
Author_xml | – sequence: 1 givenname: E. surname: Khoshbin fullname: Khoshbin, E. organization: Cardiothoracic Surgery, Newcastle Upon Tyne Hos NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom – sequence: 2 givenname: M. surname: Hudson fullname: Hudson, M. organization: Hepatobiliary Medicine, Newcastle Upon Tyne Hos NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom – sequence: 3 givenname: J. surname: Dark fullname: Dark, J. organization: Cardiothoracic Surgery, Newcastle Upon Tyne Hos NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom – sequence: 4 givenname: G. surname: Meachery fullname: Meachery, G. organization: Respiratory and Transplant Medicine, Newcastle Upon Tyne Hos NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom – sequence: 5 givenname: S. surname: Clark fullname: Clark, S. organization: Cardiothoracic Surgery, Newcastle Upon Tyne Hos NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom |
BookMark | eNp9kNFOwjAUhhuDiYC-gRd9gc3Tjm3djYkBUZMlEIPXTdeeQQl0pB0a4stbxGuvzrn5vvz5RmTgOoeE3DNIGbDiYZtuUO2OLuXAWQosrYBdkSHL8zLJGCsH8Yc8S_ikEjdkFMIWAHiW8yH5nlm1dl2wgSpn6NKjsbpHQxfHXnd7DLRr6VL1Fl0f6JftN3R6Cr3VdG4b_8u9406didp-oqczG1AFpNPOBWsw-mjbeVof3ZquvHLhsFOuj8LO3ZLrVu0C3v3dMfmYP6-mr0m9eHmbPtWJZpOCJaIshVJG66owplATFKARWNVyaEosRKMaUZSKi6xqMDN5Di033Agl8rxqAbIxmVy8Og4OHlt58Hav_EkykOeAcisvAeU5oAQmY8CIPV4wjNs-LXoZdMygYyGPupems_8LfgCY8H-z |
ContentType | Journal Article |
Copyright | 2021 |
Copyright_xml | – notice: 2021 |
DBID | AAYXX CITATION |
DOI | 10.1016/j.healun.2021.01.901 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1557-3117 |
EndPage | S318 |
ExternalDocumentID | 10_1016_j_healun_2021_01_901 S1053249821009153 |
GroupedDBID | --- --K .1- .FO .GJ 0R~ 123 1B1 1P~ 1~5 29K 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AAIAV AALRI AAQFI AAQQT AAQXK AAXUO ABFRF ABJNI ABLJU ABMAC ABOCM ACGFO ACIUM ADBBV ADMUD ADPAM AEFWE AENEX AEVXI AFRHN AFTJW AGZHU AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS ALXNB AMRAJ ASPBG AVWKF AZFZN BELOY C5W CS3 D-I DU5 EBS EFJIC EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W J5H KOM M41 MO0 N9A NQ- O9- OA- OL. R2- RIG ROL RPZ SDG SEL SES SSZ UV1 XH2 Z5R ZA5 ZGI ZXP AAYXX ADVLN AFCTW AFJKZ CITATION |
ID | FETCH-LOGICAL-c1461-8778aadcc96dd6a4e80ce019f20b7e68bab867a2839be3d550f2d2d8a8559f003 |
ISSN | 1053-2498 |
IngestDate | Thu Sep 26 18:11:21 EDT 2024 Sat Apr 13 16:39:00 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1461-8778aadcc96dd6a4e80ce019f20b7e68bab867a2839be3d550f2d2d8a8559f003 |
OpenAccessLink | https://doi.org/10.1016/j.healun.2021.01.901 |
ParticipantIDs | crossref_primary_10_1016_j_healun_2021_01_901 elsevier_sciencedirect_doi_10_1016_j_healun_2021_01_901 |
PublicationCentury | 2000 |
PublicationDate | April 2021 2021-04-00 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: April 2021 |
PublicationDecade | 2020 |
PublicationTitle | The Journal of heart and lung transplantation |
PublicationYear | 2021 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0002352 |
Score | 2.3616128 |
Snippet | Anxiety associated with poor post operative outcomes has led to patients with Cystic Fibrosis Related Liver Disease (CFRLD) being denied a chance of lung... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | S318 |
Title | Diagnosis and Predicted Outcomes of Patients with Cystic Fibrosis Related Liver Disease Considered for Lung Transplantation |
URI | https://dx.doi.org/10.1016/j.healun.2021.01.901 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NTxsxELVSuHCpWrUVlLaaQ2_VRpv99B4RH0JACiqgclvZa69ohBIE2UPbP9Wf2Jkde7NpEKJcVoklZx3P0_iNPfMsxOeoinVWqzhIbCqDRGdVIHVaBwVyDxuSHHQrsTH-mh1eJkdX6dVg8KeXtdTM9bD69WBdyXOsim1oV6qS_Q_Ldj-KDfgZ7YtPtDA-n2TjPc6T-3Hvcv7p0IUY5Gkzx9exnOwZC6e6Krbdn6TL_OUAg-S2X5sLhz1OKD2DpDjptKZ3i2ebhXiCDsGpoN-oae_sfrKAWo_Y0h3ZnLd-0_AlFCsdycNfz-6vNSsY7A8X6PIlYOOubc-lcx91LWOWoeYim2F_4yIa9fJd2t00X1GzlPCJdC8OMCRkn2ydU05pL5VrPL3XZpEnh86k54LPY-fQ7dLXlaWCdy0mQyLkDSnhRiMScC3cEJdFuM9pXDQsjJCRYaXxC7Ee5UWK4f76zvG378fd6h_FKZ-wu__hyzXbnMLVdz1Mh3oU5-KVeOlMCDsMtNdiYKdvxO8OZIAmhQ5k4EEGsxo8yIBABgwy8CADBzJoQQYOZLAAGSDIgEAG_4Dsrbg82L_YPQzcjR1BRffD49KaS6VMVRWZMZlKrAwri0FEHYU6t5nUSsssV0hpC21jg9FxHZnISCUxsK1xgXkn1qazqd0UoOM0zApkT1KRgJGRicQprU0S6sSEo3BLBH7iylsWZil9xuKk5IkuaaLLcFTiRG-J3M9u6cglk8YSAfFoz_fP7rktNhbA_yDW5neN_Ygcdq4_Odj8BfonoL0 |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis+and+Predicted+Outcomes+of+Patients+with+Cystic+Fibrosis+Related+Liver+Disease+Considered+for+Lung+Transplantation&rft.jtitle=The+Journal+of+heart+and+lung+transplantation&rft.au=Khoshbin%2C+E.&rft.au=Hudson%2C+M.&rft.au=Dark%2C+J.&rft.au=Meachery%2C+G.&rft.date=2021-04-01&rft.pub=Elsevier+Inc&rft.issn=1053-2498&rft.eissn=1557-3117&rft.volume=40&rft.issue=4&rft.spage=S318&rft.epage=S318&rft_id=info:doi/10.1016%2Fj.healun.2021.01.901&rft.externalDocID=S1053249821009153 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-2498&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-2498&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-2498&client=summon |